Influvac
Brand Name: Influvac
Generic Name: Trivalent Influenza Vaccine (Surface Antigen) 2025 Southern Hemisphere Strain
Active
Registration Number
BR-901
Dosage Form
Suspension for Injection (IM/SC)
Issuance Date
March 24, 2025
Expiry Date
March 24, 2026
Product Information
Philippine FDA product specifications and classification details
Product Specifications
Dosage StrengthEach dose (0.5 mL) contains the following strains*:
(A/Victoria/4897/2022, IVR-238)
A/Victoria/4897/2022 (H1N1) pdm09-like virus
A/Croatia/10136RV/2023 (H3N2) - like virus
(A/Croatia/10136RV/2023, X-425A)
15 ug HA**
15 ug HA**
15 ug HA**
B/Austria/1359417/2021 - like strain virus
(B/Austria/1359417/2021 - BVR-26)
*Propagated in embryonated chicken eggs **Haemagglutinin
Packaging0.5 mL in 1 mL USP Type I pre-filled glass syringe with grey bromobutyl rubber plunger with needle (Box of 1's and 10's)
Classification
C
Classification
Prescription Drug (RX)
P
Pharmacologic
Vaccines
A
Application
Monitored Release (Strain Clearance)
Philippine FDA Classification
Active Ingredients (1)
Complete list of active ingredients in this pharmaceutical product.
Trivalent Influenza Vaccine (Surface Antigen) 2025 Southern Hemisphere StrainActive
Monograph: trivalent influenza vaccine (surface antigen) 2025 southern hemisphere strain